Metabolic diseases are a family of related disorders linked mechanistically and driven in large part by subtle, long-term dysregulation of lipid metabolism. Lipomics provides quantitative measurements of over 1,500 metabolites with diagnostic accuracy, allowing comprehensive profiling of whole body lipid metabolism. Our quantitative methods and expertise in lipid biology drive our development of clinically relevant diagnostics and research assays.
Lipomics is leading the way in developing lipid based diagnostics to improve individualized health management.